Press Releases Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen Other stock markets 08:29:46 29/04/2024 pm IST			After market 08:49:31 pm
884.8 ^DKK	-0.20%		885.4	+0.07%

05:47pm	One dose of Novo Nordisk's Wegovy back in supply, FDA website shows	RE
03:11pm	Big tech saves the day, again

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nanexa invites to Capital Markets Day on May 7	03:00pm	AQ
Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	26/04	AQ
Novo Nordisk A/S : Reduction of the share capital	24/04	PU
Novo Nordisk A/S - Articles of Association, April 2024	24/04	GL
Novo Nordisk A/S – Reduction of the share capital	24/04	GL
Novo Nordisk A/S - share repurchase programme	22/04	GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	21/04	AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	15/04	GL
Novo Nordisk A/S - share repurchase programme	15/04	GL
Novo Nordisk A/S - share repurchase programme	08/04	GL
Novo Nordisk A/S - share repurchase programme	02/04	GL
Revolutionizing Targeted Cancer Treatment and Radiotherapy Manufacturing: Actinium Pharmaceuticals (NYSE: ATNM) Trailblazing Journey	28/03	AQ
Fitch Affirms DBGS 2018-BIOD Mortgage Trust	28/03	AQ
Novo Nordisk A/S - share repurchase programme	25/03	GL
Novo Nordisk to buy Cardior Pharmaceuticals	25/03	AQ
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease	25/03	GL
Novo Nordisk A/S - Articles of Association 2024	25/03	GL
Novo Nordisk A/S - Articles of Association 2024	25/03	AQ
Medicare now will cover weight-loss drug Wegovy for heart patients	22/03	AQ
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities	21/03	GL